Recommended Conferences

  • Oncology & Cancer
    March 12-14, 2018 Singapore
  • Oncology Research & Cancer Stem Cells
    May 10-12, 2018 Frankfurt, Germany
  • globaloncology.conferenceseries.com/Oncology and Radiology
    June 1-2, 2018 Osaka,Japan
  • Gynecology & Gynecologic Oncology
    July 23-24, 2018 Rome, Italy
  • Cancer Science & Therapy
    August 09-10, 2018 Madrid, Spain
  • Cancer Research and Anticancer Therapies
    September 17-18, 2018 San Diego, USA
  • 36th World Cancer Conference
    October 11-13, 2018 Zurich, Switzerland

Dr. Shhyam Moorthy

Dr. Shhyam Moorthy
The University of Texas M.D. Anderson Cancer Center, USA.
 
Biography
Doctor of Philosophy, Ph.D. | 2010-2015 | University of Texas Graduate School of Biomedical Sciences and M.D. Anderson Cancer Center, Houston, TX. Bachelor of Science (Honors), B.S. | 2006-2010 | Louisiana State University, Baton Rouge, LA.
 
Research Interest
Basic Science Expertise:- NOTCH signaling, Head and Neck Cancers, AXL signaling pathway, signal transduction, transcription and translation, targeted therapy, oncogenes and tumor suppressors, pre-clinical mice models. Clinical Expertise:- Phase 1 clinical trial design, BOIN and modified-Fibonacci dose escalation, immunotherapy, targeted therapy, drug-related toxicities, RECIST evaluation for tumor progression.Technique expertise: Mammalian Tissue Culture, RNA extraction, molecular cloning, western blots, immunohistochemistry, in vivo orthotopic tumor models, flow cytometry, retroviral and lentiviral transductions, transfections, drug-dose study, stable knock down, overexpression studies, transient electroporation, competitive cell proliferation assays, senescence, CRISPR-Cas9 knockouts, clonogenic assays, live-cell imaging, transwell invasion/migration assays and qRT-PCR.
 

Relevant Conferences